(Q44027980)

English

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

scientific article published on September 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy (English)

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Krystal L. Edwards

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

Daniel M. Riche

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

Jeffrey S. Stroup

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

Jennifer D. Goldman-Levine

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

Rosalyn S. Padiyara

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

L. Brian Cross

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

Michael P. Kane

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795850

2 July 2024

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1592%2Fphco.30.9.955

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

https://onlinelibrary.wiley.com/doi/full/10.1592/phco.30.9.955

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

955-965

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The relation of type 2 diabetes and cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Cancer as an endocrine problem

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of bladder cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Colorectal cancer: another complication of diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

A case-control study of diabetes mellitus and cancer risk

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The IGF-I receptor in cancer research

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The role of the IGF system in cancer: from basic to clinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Growth effects of insulin and insulin analogues

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glargine and malignancy: an unwarranted alarm

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glulisine--a comprehensive preclinical evaluation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Gastric cancer in very young adults: apropos four patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

A 5' Leader of Rbm3, a Cold Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased Efficiency under Conditions of Mild Hypothermia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The IGF system and breast cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin-like growth factor 1 (IGF-1): a growth hormone

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Novel insulin analogues and its mitogenic potential

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells

3

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin analogues

4

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

7

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

10

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

21

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis

26

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

29

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin induction of protein kinase C alpha expression is independent of insulin receptor Tyr1162/1163 residues and involves mitogen-activated protein kinase kinase 1 and sustained activation of nuclear p44MAPK.

31

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

39

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence

45

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1

52

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expressionin Vitroandin Vivo

54

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

59

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

64

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Insulin glargine and cancer--an unsubstantiated allegation

68

1 reference

10.1592/PHCO.30.9.955

https://api.crossref.org/works/10.1592/PHCO.30.9.955

2 July 2024

Identifiers

10.1592/PHCO.30.9.955

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44027980&oldid=2193637886"